Luigia Elzi
Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Lubomirov R, Telenti A, Günthard H, Furrer H, Vernazza P, Elzi L, Bernasconi E, Hirschel B, Cavassini M, Martinez R, Ledergerber B, di Iulio J, Colombo S, the Swiss HIV Cohort Study. Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study. J Infect Dis 2010; 203:246-257.
Dec 9, 2010Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Dec 9, 2010J Infect Dis 2010; 203:246-257
Lubomirov Rubin, Telenti Amalio, Günthard Huldrych F, Furrer Hansjakob, Vernazza Pietro, Elzi Luigia, Bernasconi Enos, Hirschel Bernard, Cavassini Matthias, Martinez Raquel, Ledergerber Bruno, di Iulio Julia, Colombo Sara, the Swiss HIV Cohort Study
Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
Rotger M, Tarr P, Telenti A, Egger M, Ledergerber B, Weber R, Furrer H, Hirschel B, Bernasconi E, Cavassini M, Vernazza P, Elzi L, Taffé P, Martinez R, Gsponer T, Swiss HIV Cohort Study. Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals. Clin Infect Dis 2010; 51:1090-8.
Nov 1, 2010Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
Nov 1, 2010Clin Infect Dis 2010; 51:1090-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Egger Matthias, Ledergerber Bruno, Weber Rainer, Furrer Hansjakob, Hirschel Bernard, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Elzi Luigia, Taffé Patrick, Martinez Raquel, Gsponer Thomas, Swiss HIV Cohort Study
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
Hasse B, Weber R, Nicca D, Bernasconi E, Cavassini M, Elzi L, Evison J, Jeannin A, Glass T, Vernazza P, Hirschel B, Ledergerber B, Swiss HIV Cohort Study. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51:1314-22.
Oct 29, 2010Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
Oct 29, 2010Clin Infect Dis 2010; 51:1314-22
Hasse Barbara, Weber Rainer, Nicca Dunja, Bernasconi Enos, Cavassini Matthias, Elzi Luigia, Evison John-Marc, Jeannin Andre, Glass Tracy R, Vernazza Pietro, Hirschel Bernard, Ledergerber Bruno, Swiss HIV Cohort Study
Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study
Thurnheer M, Furrer H, Zwahlen M, Christen A, Bernasconi E, Schmid P, Elzi L, Cavassini M, Toutous-Trellu L, Weber R, Swiss HIV Cohort Study. Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS 2010; 24:1907-16.
Jul 31, 2010Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study
Jul 31, 2010AIDS 2010; 24:1907-16
Thurnheer Maria Christine, Furrer Hansjakob, Zwahlen Marcel, Christen Anna B, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Cavassini Matthias, Toutous-Trellu Laurence, Weber Rainer, Swiss HIV Cohort Study
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008
Elzi L, Battegay M, Weber R, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Ledergerber B, Furrer H, Marzolini C, Swiss HIV Cohort Study. Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Archives of internal medicine 2010; 170:57-65.
Jan 11, 2010Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008
Jan 11, 2010Archives of internal medicine 2010; 170:57-65
Elzi Luigia, Battegay Manuel, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Ledergerber Bruno, Furrer Hansjakob, Marzolini Catia, Swiss HIV Cohort Study
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia
Ferry T, Calmy A, Schmid P, Bernasconi E, Elzi L, Weber R, Rauch A, Delhumeau C, Meylan P, Dang T, Hirschel B, Swiss HIV Cohort Study. Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 50:115-8.
Jan 1, 2010Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemia
Jan 1, 2010Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010; 50:115-8
Ferry Tristan, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Elzi Luigia, Weber Rainer, Rauch Andri, Delhumeau Cécile, Meylan Pascal, Dang Thanh, Hirschel Bernard, Swiss HIV Cohort Study
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Marzolini C, Battegay M, Back D, Ledergerber B, Khoo S, Vernazza P, Calmy A, Bernasconi E, Cavassini M, Chave J, Furrer H, Fux C, Weber R, Gibbons S, Elzi L, Swiss HIV Cohort Study. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther (Lond) 2010; 15:413-23.
Jan 1, 2010Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Jan 1, 2010Antivir Ther (Lond) 2010; 15:413-23
Marzolini Catia, Battegay Manuel, Back David, Ledergerber Bruno, Khoo Saye, Vernazza Pietro, Calmy Alexandra, Bernasconi Enos, Cavassini Matthias, Chave Jean-Philippe, Furrer Hansjakob, Fux Christoph, Weber Rainer, Gibbons Sara, Elzi Luigia, Swiss HIV Cohort Study
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
Khanna N, Hirsch H, Battegay M, Bernasconi E, Vernazza P, Fux C, Cavassini M, Garzoni C, Mueller N, Elzi L, Swiss HIV Cohort Study. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66.
May 15, 2009Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study
May 15, 2009Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009; 48:1459-66
Khanna Nina, Hirsch Hans H, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fux Christoph A, Cavassini Matthias, Garzoni Christian, Mueller Nicolas J, Elzi Luigia, Swiss HIV Cohort Study
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Elzi L, Battegay M, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Fux C, Weber R, Kaufmann G, Swiss HIV Cohort Study. Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals. HIV clinical trials 2009; 10:207-14.
Jan 1, 2009Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals
Jan 1, 2009HIV clinical trials 2009; 10:207-14
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Fux Christoph A, Weber Rainer, Kaufmann Gilbert, Swiss HIV Cohort Study
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Simcock M, Rauch A, Swiss HIV Cohort Study. Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral therapy 2008; 13:1077-82.
Jan 1, 2008Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study
Jan 1, 2008Antiviral therapy 2008; 13:1077-82
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Simcock Mathew, Rauch Andri, Swiss HIV Cohort Study
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
Arnedo M, Tarr P, Telenti A, Beckmann J, Bergmann S, Darioli R, Bernasconi E, Vernazza P, Weber R, Elzi L, Hirschel B, Furrer H, Sahli R, Taffé P, Swiss HIV Cohort Study. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenetics and genomics 2007; 17:755-64.
Sep 1, 2007Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy
Sep 1, 2007Pharmacogenetics and genomics 2007; 17:755-64
Arnedo Mireia, Tarr Philip E, Telenti Amalio, Beckmann Jacques S, Bergmann Sven, Darioli Roger, Bernasconi Enos, Vernazza Pietro, Weber Rainer, Elzi Luigia, Hirschel Bernard, Furrer Hansjakob, Sahli Roland, Taffé Patrick, Swiss HIV Cohort Study
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
Ledergerber B, Weber R, Egger M, Schmid P, Bernasconi E, Cavassini M, Hirschel B, Elzi L, Lehmann R, Rickenbach M, Furrer H, Swiss HIV Cohort Study. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:111-9.
Jul 1, 2007Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
Jul 1, 2007Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:111-9
Ledergerber Bruno, Weber Rainer, Egger Matthias, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Hirschel Bernard, Elzi Luigia, Lehmann Roger, Rickenbach Martin, Furrer Hansjakob, Swiss HIV Cohort Study
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Wolbers M, Simcock M, Swiss HIV Cohort Study. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antiviral therapy 2007; 12:1165-73.
Jan 1, 2007Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study
Jan 1, 2007Antiviral therapy 2007; 12:1165-73
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Wolbers Marcel, Simcock Mathew, Swiss HIV Cohort Study
Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report
Nicca D, Moody K, Elzi L, Spirig R. Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report. The Journal of the Association of Nurses in AIDS Care : JANAC 2007; 18:44-53.
Jan 1, 2007Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report
Jan 1, 2007The Journal of the Association of Nurses in AIDS Care : JANAC 2007; 18:44-53
Nicca Dunja, Moody Kimberly, Elzi Luigia, Spirig Rebecca
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
Wunder D, Furrer H, Mueller B, Bernasconi E, Schmid P, Elzi L, Cavassini M, Hirschel B, Mueller N, Fux C, Bersinger N, Swiss HIV Cohort Study. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antiviral therapy 2007; 12:261-5.
Jan 1, 2007Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
Jan 1, 2007Antiviral therapy 2007; 12:261-5
Wunder Dorothea M, Furrer Hansjakob, Mueller Bruno, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Cavassini Matthias, Hirschel Bernard, Mueller Nicolas J, Fux Christoph A, Bersinger Nick A, Swiss HIV Cohort Study
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Elzi L, Furrer H, Rickenbach M, Bernasconi E, Schmid P, Cavassini M, Hirschel B, Weber R, Schlegel M, Swiss HIV Cohort Study. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 44:94-102.
Jan 1, 2007Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Jan 1, 2007Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 44:94-102
Elzi Luigia, Furrer Hansjakob, Rickenbach Martin, Bernasconi Enos, Schmid Patrick, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Schlegel Matthias, Swiss HIV Cohort Study
Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study
Keiser O, Aebi-Popp K, Bernasconi E, Schmid P, Elzi L, Zinkernagel A, Zellweger C, Chapuis-Taillard C, Wunder D, Martinez de Tejada B, Rickenbach M. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. Journal of acquired immune deficiency syndromes (1999) 2006; 43:550-5.
Dec 15, 2006Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study
Dec 15, 2006Journal of acquired immune deficiency syndromes (1999) 2006; 43:550-5
Keiser Olivia, Aebi-Popp Karoline, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Zinkernagel Annelies S, Zellweger Claudine, Chapuis-Taillard Caroline, Wunder Dorothea, Martinez de Tejada Begoña, Rickenbach Martin
A smoking cessation programme in HIV-infected individuals: a pilot study
Elzi L, Spoerl D, Voggensperger J, Nicca D, Simcock M, Bucher H, Spirig R, Battegay M, Swiss HIV Cohort Study. A smoking cessation programme in HIV-infected individuals: a pilot study. Antiviral therapy 2006; 11:787-95.
Jan 1, 2006A smoking cessation programme in HIV-infected individuals: a pilot study
Jan 1, 2006Antiviral therapy 2006; 11:787-95
Elzi Luigia, Spoerl David, Voggensperger Jacqueline, Nicca Dunja, Simcock Mathew, Bucher Heiner C, Spirig Rebecca, Battegay Manuel, Swiss HIV Cohort Study
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Karrer U, Speck R, Weber R, Russotti M, Schmid P, Hirschel B, Gayet-Ageron A, Cavassini M, Battegay M, Elzi L, Furrer H, Ledergerber B, Swiss HIV Cohort Study. Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir. AIDS (London, England) 2005; 19:1987-94.
Nov 18, 2005Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Nov 18, 2005AIDS (London, England) 2005; 19:1987-94
Karrer Urs, Speck Roberto F, Weber Rainer, Russotti Marina, Schmid Patrick, Hirschel Bernard, Gayet-Ageron Angèle, Cavassini Matthias, Battegay Manuel, Elzi Luigia, Furrer Hansjakob, Ledergerber Bruno, Swiss HIV Cohort Study